Literature DB >> 17406842

Polymeric formula has direct anti-inflammatory effects on enterocytes in an in vitro model of intestinal inflammation.

Naomi S H de Jong1, Steven T Leach, Andrew S Day.   

Abstract

Exclusive enteral nutrition using polymeric formula (PF) is a well-established therapeutic option for active Crohn's disease; however, its mechanisms of action are unknown. We investigated the anti-inflammatory effects of PF in an in vitro model of epithelial cell inflammation. PF did not affect cell viability over a range of dilutions, but when PF was added to the culture medium the interleukin (IL)-8 response to proinflammatory stimuli was significantly reduced. This effect was due to PF acting directly on the cells as the IL-8 response was still reduced when PF was separated from the proinflammatory stimuli in a 2-compartment system. In the presence of PF, nuclear factor (NF)-kappaB nuclear migration was not inhibited; however, IkappaBalpha degradation was delayed. PF has direct anti-inflammatory effects upon immortalized colonic enterocytes. Therefore PF may, in part, modulate gut inflammation by directly reducing the inflammatory response of the intestinal epithelium.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17406842     DOI: 10.1007/s10620-006-9449-x

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  36 in total

Review 1.  Etiology and pathogenesis of inflammatory bowel disease.

Authors:  C Schmidt; A Stallmach
Journal:  Minerva Gastroenterol Dietol       Date:  2005-06

Review 2.  Childhood Crohn's disease and the efficacy of enteral diets.

Authors:  R M Beattie; B S Bentsen; T T MacDonald
Journal:  Nutrition       Date:  1998-04       Impact factor: 4.008

3.  Regulation of intestinal epithelial barrier function by TGF-beta 1. Evidence for its role in abrogating the effect of a T cell cytokine.

Authors:  S M Planchon; C A Martins; R L Guerrant; J K Roche
Journal:  J Immunol       Date:  1994-12-15       Impact factor: 5.422

Review 4.  Enteric bacteria, lipopolysaccharides and related cytokines in inflammatory bowel disease: biological and clinical significance.

Authors:  L Caradonna; L Amati; T Magrone; N M Pellegrino; E Jirillo; D Caccavo
Journal:  J Endotoxin Res       Date:  2000

Review 5.  Multiple control of interleukin-8 gene expression.

Authors:  Elke Hoffmann; Oliver Dittrich-Breiholz; Helmut Holtmann; Michael Kracht
Journal:  J Leukoc Biol       Date:  2002-11       Impact factor: 4.962

Review 6.  Crohn's disease: nutrition and nutritional therapy.

Authors:  A Ferguson; M Glen; S Ghosh
Journal:  Baillieres Clin Gastroenterol       Date:  1998-03

7.  Tumor necrosis factor alpha-producing cells in the intestinal mucosa of children with inflammatory bowel disease.

Authors:  E J Breese; C A Michie; S W Nicholls; S H Murch; C B Williams; P Domizio; J A Walker-Smith; T T MacDonald
Journal:  Gastroenterology       Date:  1994-06       Impact factor: 22.682

8.  Elemental versus polymeric enteral nutrition in paediatric Crohn's disease: a multicentre randomized controlled trial.

Authors:  J F Ludvigsson; M Krantz; L Bodin; L Stenhammar; B Lindquist
Journal:  Acta Paediatr       Date:  2004-03       Impact factor: 2.299

9.  Aspirin inhibits TNFalpha- and IL-1-induced NF-kappaB activation and sensitizes HeLa cells to apoptosis.

Authors:  Ozgur Kutuk; Huveyda Basaga
Journal:  Cytokine       Date:  2004-03-07       Impact factor: 3.861

Review 10.  Inflammatory bowel diseases in pediatric and adolescent patients: clinical, therapeutic, and psychosocial considerations.

Authors:  Sandra C Kim; George D Ferry
Journal:  Gastroenterology       Date:  2004-05       Impact factor: 22.682

View more
  25 in total

1.  Longer-term outcomes of nutritional management of Crohn's disease in children.

Authors:  B Lambert; D A Lemberg; S T Leach; A S Day
Journal:  Dig Dis Sci       Date:  2012-06-02       Impact factor: 3.199

2.  Differential effects of nutritional and non-nutritional therapies on intestinal barrier function in an in vitro model.

Authors:  Lily Nahidi; Andrew S Day; Daniel A Lemberg; Steven T Leach
Journal:  J Gastroenterol       Date:  2011-09-28       Impact factor: 7.527

Review 3.  An update of the role of nutritional therapy in the management of Crohn's disease.

Authors:  Moftah H Alhagamhmad; Andrew S Day; Daniel A Lemberg; Steven T Leach
Journal:  J Gastroenterol       Date:  2012-06-15       Impact factor: 7.527

Review 4.  Nutritional status and nutritional therapy in inflammatory bowel diseases.

Authors:  Corina Hartman; Rami Eliakim; Raanan Shamir
Journal:  World J Gastroenterol       Date:  2009-06-07       Impact factor: 5.742

Review 5.  Nutritional Strategies in the Management of Adult Patients with Inflammatory Bowel Disease: Dietary Considerations from Active Disease to Disease Remission.

Authors:  Douglas L Nguyen; Berkeley Limketkai; Valentina Medici; Mardeli Saire Mendoza; Lena Palmer; Matthew Bechtold
Journal:  Curr Gastroenterol Rep       Date:  2016-10

Review 6.  Exclusive enteral nutrition in children with Crohn's disease.

Authors:  Andrew S Day; Robert N Lopez
Journal:  World J Gastroenterol       Date:  2015-06-14       Impact factor: 5.742

7.  The major pathway by which polymeric formula reduces inflammation in intestinal epithelial cells: a microarray-based analysis.

Authors:  Lily Nahidi; Susan M Corley; Marc R Wilkins; Jerry Wei; Moftah Alhagamhmad; Andrew S Day; Daniel A Lemberg; Steven T Leach
Journal:  Genes Nutr       Date:  2015-07-17       Impact factor: 5.523

8.  Predictors of response to enteral nutrition in abdominal enterocutaneous fistula patients with Crohn's disease.

Authors:  D Yan; J Ren; G Wang; S Liu; J Li
Journal:  Eur J Clin Nutr       Date:  2014-03-12       Impact factor: 4.016

9.  Osteoprotegerin exerts its pro-inflammatory effects through nuclear factor-κB activation.

Authors:  Lily Nahidi; Steven T Leach; Daniel A Lemberg; Andrew S Day
Journal:  Dig Dis Sci       Date:  2013-09-19       Impact factor: 3.199

10.  Effect of exclusive enteral nutrition on bone turnover in children with Crohn's disease.

Authors:  Kylie E Whitten; Steven T Leach; Timothy D Bohane; Helen J Woodhead; Andrew S Day
Journal:  J Gastroenterol       Date:  2009-12-03       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.